Epigenetic silencing of the 3p22 tumor suppressor DLEC1 by promoter CpG methylation in non-Hodgkin and Hodgkin lymphomas
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Epigenetic silencing of the 3p22 tumor suppressor DLEC1 by promoter CpG methylation in non-Hodgkin and Hodgkin lymphomas ; volume:10 ; number:1 ; day:11 ; month:10 ; year:2012 ; pages:1-7 ; date:12.2012
Journal of translational medicine ; 10, Heft 1 (11.10.2012), 1-7, 12.2012
- Urheber
-
Wang, Zhaohui
- Beteiligte Personen und Organisationen
-
Li, Lili
Su, Xianwei
Gao, Zifen
Srivastava, Gopesh
Murray, Paul G.
Ambinder, Richard
Tao, Qian
SpringerLink (Online service)
- DOI
-
10.1186/1479-5876-10-209
- URN
-
urn:nbn:de:1111-2016041440396
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wang, Zhaohui
- Li, Lili
- Su, Xianwei
- Gao, Zifen
- Srivastava, Gopesh
- Murray, Paul G.
- Ambinder, Richard
- Tao, Qian
- SpringerLink (Online service)
Ähnliche Objekte (12)
FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas
The management of Non-Hodgkin's Lymphomas in Europe
Cytokine expression in B-cell non-Hodgkin lymphomas
Current immunotherapeutic approaches in T cell non-Hodgkin lymphomas
Detection of the (2;5)(p23;q35) translocation in non-Hodgkin and Hodgkin Lymphomas
Histopathology of Non-Hodgkin's lymphomas : (based on the Kiel classification)
Lymphozytenmigration bei Non-Hodgkin- und Hodgkin-Lymphomen
Histopathology of Non-Hodgkin's lymphomas : (based on the updated Kiel classification)
Profile of Childhood Non-Hodgkin Lymphomas at a Tertiary Care Hospital
Survival trend and outcome prediction for pediatric Hodgkin and non-Hodgkin lymphomas based on machine learning
Constitutive overexpression of a novel 21 kDa protein by Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphomas
Spectrum of common Hodgkin lymphoma and non-Hodgkin lymphomas subtypes in Zambia: a 3-year records review
FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas
The management of Non-Hodgkin's Lymphomas in Europe
Cytokine expression in B-cell non-Hodgkin lymphomas
Current immunotherapeutic approaches in T cell non-Hodgkin lymphomas
Detection of the (2;5)(p23;q35) translocation in non-Hodgkin and Hodgkin Lymphomas
Histopathology of Non-Hodgkin's lymphomas : (based on the Kiel classification)
Lymphozytenmigration bei Non-Hodgkin- und Hodgkin-Lymphomen
Histopathology of Non-Hodgkin's lymphomas : (based on the updated Kiel classification)
Profile of Childhood Non-Hodgkin Lymphomas at a Tertiary Care Hospital
Survival trend and outcome prediction for pediatric Hodgkin and non-Hodgkin lymphomas based on machine learning
Constitutive overexpression of a novel 21 kDa protein by Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphomas
Spectrum of common Hodgkin lymphoma and non-Hodgkin lymphomas subtypes in Zambia: a 3-year records review
FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas
The management of Non-Hodgkin's Lymphomas in Europe
Cytokine expression in B-cell non-Hodgkin lymphomas
Current immunotherapeutic approaches in T cell non-Hodgkin lymphomas
Detection of the (2;5)(p23;q35) translocation in non-Hodgkin and Hodgkin Lymphomas
Histopathology of Non-Hodgkin's lymphomas : (based on the Kiel classification)
Lymphozytenmigration bei Non-Hodgkin- und Hodgkin-Lymphomen
Histopathology of Non-Hodgkin's lymphomas : (based on the updated Kiel classification)
Profile of Childhood Non-Hodgkin Lymphomas at a Tertiary Care Hospital
Survival trend and outcome prediction for pediatric Hodgkin and non-Hodgkin lymphomas based on machine learning
Constitutive overexpression of a novel 21 kDa protein by Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphomas